Testosterone therapy in HIV wasting syndrome: systematic review and meta-analysis (Q34985014)

5 August 2017

0 references

1 reference

title

Testosterone therapy in HIV wasting syndrome: systematic review and meta-analysis (English)

1 reference

5 August 2017

0 references

1 reference

1 reference

1 reference

1 reference

Anthony Kong

1

1 reference

5 August 2017

Polly Edmonds

series ordinal

2

1 reference

5 August 2017

publication date

1 November 2002

1 reference

Lancet Infectious Diseases

5 August 2017

published in

1 reference

5 August 2017

volume

2

1 reference

5 August 2017

issue

11

1 reference

5 August 2017

page(s)

692-699

1 reference

Early changes of body composition in human immunodeficiency virus-infected patients: tetrapolar body impedance analysis indicates significant malnutrition

5 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900441-3

7 January 2021

Magnitude of body-cell-mass depletion and the timing of death from wasting in AIDS

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900441-3

7 January 2021

Body composition studies in patients with the acquired immunodeficiency syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900441-3

7 January 2021

Treatment guidelines for HIV-associated wasting

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900441-3

7 January 2021

The five-level model: a new approach to organizing body-composition research

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900441-3

7 January 2021

The effect of protease inhibitors on weight and body composition in HIV-infected patients

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900441-3

7 January 2021

Beneficial effects of protease inhibitors on body composition and energy expenditure: a comparison between HIV-infected and AIDS patients

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900441-3

7 January 2021

Megestrol acetate for treatment of cachexia associated with human immunodeficiency virus (HIV) infection

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900441-3

7 January 2021

Thalidomide pros and cons

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900441-3

7 January 2021

Effects of thalidomide on HIV-associated wasting syndrome: a randomized, double-blind, placebo-controlled clinical trial.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900441-3

7 January 2021

Thalidomide for the treatment of AIDS-associated wasting

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900441-3

7 January 2021

Recombinant human growth hormone, insulin-like growth factor 1, and combination therapy in AIDS-associated wasting. A randomized, double-blind, placebo-controlled trial.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900441-3

7 January 2021

Recombinant human growth hormone in patients with HIV-associated wasting. A randomized, placebo-controlled trial. Serostim Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900441-3

7 January 2021

Changes in the hypothalamic-pituitary-gonadal axis in human immunodeficiency virus-infected homosexual men.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900441-3

7 January 2021

Endocrine disorders in men infected with human immunodeficiency virus

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900441-3

7 January 2021

The effects of supraphysiologic doses of testosterone on muscle size and strength in normal men.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900441-3

7 January 2021

Effects of androgen administration in men with the AIDS wasting syndrome. A randomized, double-blind, placebo-controlled trial.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900441-3

7 January 2021

Effects of testosterone and progressive resistance training in eugonadal men with AIDS wasting. A randomized, controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900441-3

7 January 2021

Testosterone replacement and resistance exercise in HIV-infected men with weight loss and low testosterone levels

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900441-3

7 January 2021

Oxandrolone in AIDS-wasting myopathy

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900441-3

7 January 2021

A trial of testosterone therapy for HIV-associated weight loss

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900441-3

7 January 2021

The use of a transscrotal testosterone delivery system in the treatment of patients with weight loss related to human immunodeficiency virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900441-3

7 January 2021

Sustained anabolic effects of long-term androgen administration in men with AIDS wasting

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900441-3

7 January 2021

Oxymetholone promotes weight gain in patients with advanced human immunodeficiency virus (HIV-1) infection

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900441-3

7 January 2021

Testosterone therapy for human immunodeficiency virus-positive men with and without hypogonadism

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900441-3

7 January 2021

DHEA treatment for HIV+ patients: effects on mood, androgenic and anabolic parameters

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900441-3

7 January 2021

A double-blind, placebo-controlled trial of testosterone therapy for HIV-positive men with hypogonadal symptoms

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900441-3

7 January 2021

Resistance exercise and supraphysiologic androgen therapy in eugonadal men with HIV-related weight loss: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900441-3

7 January 2021

Effects of nandrolone decanoate therapy in borderline hypogonadal men with HIV-associated weight loss

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900441-3

7 January 2021

Monitoring changes in fat-free mass in HIV-positive men with hypotestosteronemia and AIDS wasting syndrome treated with gonadal hormone replacement therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900441-3

7 January 2021

Diagnosis, prediction, and natural course of HIV-1 protease-inhibitor-associated lipodystrophy, hyperlipidaemia, and diabetes mellitus: a cohort study

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900441-3

7 January 2021

Short-term progressive resistance training increases strength and lean body mass in adults infected with human immunodeficiency virus

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900441-3

7 January 2021

10.1016/S1473-3099(02)00441-3

Identifiers

DOI

1 reference

5 August 2017

1 reference